Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Table 1

Clinical characteristics.

Patients		379
Sex	Male : Female	176 : 203
Age at 2nd-Line chemo (years)	Median (Range)	50 (18–81)
Histology	Leiomyosarcoma	134 (35.4%)
	Synovial sarcoma	52 (13.7%)
	Liposarcoma	39(10.3%)
	Other:	154 (40.6%)
	Malignant Fibrous Histiocytoma	25
	Sarcoma (not otherwise specified)	30
	Fibrosarcoma	9
	Malignant Peripheral nerve sheath tumour	12
	Angiosarcoma	18
	Other	60
	Disease	Advanced	40 (10.6%)
Metastatic—single organ		186 (49.1%)
Metastatic—multiple organs		153 (40.4%)
Sites of metastases	Lung	231 (60.9%)
	Liver	73 (19.3%)
	Bone	23 (6.1%)